Draft Guidance from FDA Introduces Important Changes to Drug Development for Rare Diseases
On February 23, 2026, FDA issued a Draft Guidance document, called “Considerations for the use of the Plausible Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with Known Biological…